Fig. 1 · Structure

Documents & Downloads

TAK-593

Cat. No. A13555 CAS 1005780-62-0

VEGFR/PDGFR inhibitor

TAK-593 is an oral formulation containing a small-molecule receptor tyrosine kinase inhibitor of both vascular endothelial growth factor receptor (VEGFR) and platelet-derived growth factor receptor (PDGFR) with potential antineoplastic activity.

In Stock

Free Aliquoting for Your Order

Tell us your preferred amount per vial. We’ll confirm the options.

Biological Activity

Target & Activity

Target Activity Value
VEGFR1 IC50 3.2 nM
VEGFR2 IC50 0.95 nM
VEGFR3 IC50 1.1 nM
PDGFRα IC50 4.3 nM
PDGFRβ IC50 13 nM
PDGFRαV561D IC50 1 nM

6 targets · Scroll to view more

Cellular Effect

Cell Line Activity Value Description Reference
HUVEC IC50 0.3 nM Antiproliferative activity against VEGF-stimulated HUVECs after 5 days by WST-8 assay [PMID: 23498918]

Specifications

Manufacturer Adooq Bioscience
Actions Inhibitor
CAS Number 1005780-62-0
Applications VEGFR/PDGFR inhibitor
Formula C23H23N7O3
Molecular Weight 445.47382
SMILES
CC1=C(C=C(C=C1)OC2=NN3C=C(N=C3C=C2)NC(=O)C4CC4)NC(=O)C5=CC(=NN5C)C

Storage & Solubility

In Vitro Solubility

Reported Solubility

No reported solubility data are available for this product.

Preparing Stock Solutions

Stock preparation is unavailable for this product molecular weight.

Calculated stock concentrations do not establish solvent solubility. Refer to the reported solubility data for experimental guidance.

Storage

Store powder at -20°C, keep desiccated.
In powder form, the chemical is stable for 36 months.
In solution, store at -20°C and use within 1 month to prevent loss of potency. Aliquot to avoid multiple freeze/thaw cycles.

Added to your cart

View Cart Checkout
Loading...